Hui Feng

Assistant Professor, Pharmacology & Experimental Therapeutics

Research Interests & Expertise:
Identifying novel genes and pathways that are essential for MYC-related tumor transformation and progression, particularly for T-Lymphoblastic Lymphoma/Leukemia, Neuroblastoma and Breast Cancer
Determining the molecular mechanisms underlying tumor cell intravasation and tumor progression
Identifying novel genes and pathways that, when mutated, delay the initiation and progression of MYC-related cancers
Testing the identified genes’ therapeutic potential in treating MYC-related cancers and to characterize their molecular relevance to MYC

Websites:
Feng Lab website
Pharmacology & Experimental Therapeutics Faculty
International meeting speaker
Cancer Cell paper preview
Fis’ing for Answers

Departments & Programs:
Dept of Pharmacology & Experimental Therapeutics